Symbiosal(®) and lowering of blood pressure and reduced risk of hypertension: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006

Following an application from Han‐Biotech GmbH, submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of Germany, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scien...

Descripción completa

Detalles Bibliográficos
Autores principales: Turck, Dominique, Bresson, Jean‐Louis, Burlingame, Barbara, Dean, Tara, Fairweather‐Tait, Susan, Heinonen, Marina, Hirsch‐Ernst, Karen Ildico, Mangelsdorf, Inge, McArdle, Harry J, Naska, Androniki, Neuhäuser‐Berthold, Monika, Nowicka, Grażyna, Pentieva, Kristina, Sanz, Yolanda, Sjödin, Anders, Stern, Martin, Tomé, Daniel, Van Loveren, Henk, Vinceti, Marco, Willatts, Peter, Martin, Ambroise, Strain, Sean (J.J.), Siani, Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Scientific Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009733/
https://www.ncbi.nlm.nih.gov/pubmed/32625995
http://dx.doi.org/10.2903/j.efsa.2018.5364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009733/
https://www.ncbi.nlm.nih.gov/pubmed/32625995
http://dx.doi.org/10.2903/j.efsa.2018.5364

Ejemplares similares